ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,238 | -73.3% | 54,915 | +3.2% | 0.00% | – |
| Q2 2023 | $27,145 | -1.9% | 53,225 | +21.2% | 0.00% | – |
| Q1 2023 | $27,666 | -4.7% | 43,914 | -1.8% | 0.00% | – |
| Q4 2022 | $29,016 | -100.0% | 44,702 | -24.0% | 0.00% | – |
| Q3 2022 | $101,217,000 | +132.3% | 58,847 | +67.5% | 0.00% | – |
| Q2 2022 | $43,577,000 | +260.0% | 35,143 | +89.4% | 0.00% | – |
| Q1 2022 | $12,106,000 | -73.9% | 18,556 | -56.4% | 0.00% | – |
| Q4 2021 | $46,397,000 | -34.3% | 42,566 | +9.7% | 0.00% | – |
| Q3 2021 | $70,598,000 | +191.6% | 38,790 | +323.0% | 0.00% | – |
| Q2 2021 | $24,211,000 | -89.9% | 9,171 | -86.3% | 0.00% | – |
| Q1 2021 | $240,714,000 | +244.3% | 66,865 | +141.0% | 0.00% | – |
| Q4 2020 | $69,910,000 | -42.9% | 27,742 | -42.9% | 0.00% | – |
| Q3 2020 | $122,414,000 | +96.1% | 48,577 | +155.2% | 0.00% | – |
| Q2 2020 | $62,428,000 | -69.1% | 19,033 | -76.9% | 0.00% | – |
| Q1 2020 | $201,936,000 | +108.6% | 82,423 | +301.9% | 0.00% | – |
| Q4 2019 | $96,798,000 | -17.5% | 20,508 | -25.2% | 0.00% | – |
| Q3 2019 | $117,268,000 | +18.4% | 27,399 | +61.3% | 0.00% | – |
| Q2 2019 | $99,017,000 | -13.4% | 16,984 | -42.8% | 0.00% | – |
| Q1 2019 | $114,322,000 | +8.0% | 29,694 | +1274.1% | 0.00% | – |
| Q4 2018 | $105,863,000 | -45.8% | 2,161 | -67.4% | 0.00% | – |
| Q3 2018 | $195,475,000 | +6.4% | 6,636 | +4.4% | 0.00% | – |
| Q2 2018 | $183,634,000 | +66.9% | 6,356 | -77.4% | 0.00% | – |
| Q1 2018 | $110,003,000 | -2.8% | 28,062 | +2.6% | 0.00% | – |
| Q4 2017 | $113,188,000 | +35.4% | 27,340 | +100.8% | 0.00% | – |
| Q3 2017 | $83,615,000 | -7.4% | 13,618 | -6.2% | 0.00% | – |
| Q2 2017 | $90,339,000 | +855.7% | 14,524 | +874.1% | 0.00% | – |
| Q1 2017 | $9,453,000 | -76.9% | 1,491 | -80.5% | 0.00% | – |
| Q4 2016 | $40,885,000 | -21.0% | 7,642 | -16.9% | 0.00% | – |
| Q3 2016 | $51,745,000 | +96.1% | 9,191 | +91.2% | 0.00% | – |
| Q2 2016 | $26,390,000 | -88.2% | 4,807 | -82.1% | 0.00% | -100.0% |
| Q4 2015 | $223,190,000 | +4.1% | 26,858 | +12.9% | 0.00% | 0.0% |
| Q3 2015 | $214,393,000 | +87.2% | 23,795 | +149.4% | 0.00% | – |
| Q2 2015 | $114,504,000 | +398.5% | 9,542 | +347.4% | 0.00% | – |
| Q1 2015 | $22,972,000 | +85.6% | 2,133 | -54.5% | 0.00% | – |
| Q3 2014 | $12,379,000 | +3999.0% | 4,689 | +5482.1% | 0.00% | – |
| Q1 2014 | $302,000 | -92.1% | 84 | -90.5% | 0.00% | – |
| Q4 2013 | $3,832,000 | -92.7% | 883 | -93.4% | 0.00% | – |
| Q3 2013 | $52,768,000 | +6.0% | 13,393 | -43.5% | 0.00% | – |
| Q2 2013 | $49,793,000 | – | 23,711 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |